Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 1 50-1, 2004, Pages

  Gosmanov, Aidar R ^a   Umpierrez, Guillermo E ^b   Karabell, Ana H ^a   Cuervo, Ruben ^a   Thomason, Donald B ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt 1; Glucose transporter 4; Hyperglycemia; Insulin receptor; Insulin receptor substrate

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; PROTEIN AKT1; PROTEIN KINASE B; PROTEIN KINASE B BETA; SERINE; THREONINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIABETIC OBESITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN TREATMENT; MALE; MAMMAL; MUSCLE BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; SKELETAL MUSCLE; STIMULATION; TREATMENT OUTCOME; VASTUS LATERALIS MUSCLE;

ADULT; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION;

EID: 3042697259     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00485.2003     Document Type: Article

References (50)

1. Banerji MA, Chaiken RL, and Lebovitz HE. Long-term normoglycemic remission in black newly diagnosed NIDDM subjects. Diabetes 45: 337-341, 1996.
2. Brazil DP and Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26: 657-664, 2001.
3. Brozinick JT Jr, Roberts BR, and Dohm GL. Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Diabetes 52: 935-941, 2003.
4. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB III, Kaestner KH, Bartolomei MS, Shulman GI, and Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731, 2001.
5. Cho H, Thorvaldsen JL, Chu Q, Feng F, and Birnbaum MJ. Aktl/ PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276: 38349-38352, 2001.
6. Ciaraldi TP, Carter L, Nikoulina S, Mudaliar S, McClain DA, and Henry RR. Glucosamine regulation of glucose metabolism in cultured human skeletal muscle cells: divergent effects on glucose transport/ phosphorylation and glycogen synthase in non-diabetic and type 2 diabetic subjects. Endocrinology 140: 3971-3980, 1999.
7. Cohen P, Alessi DR, and Cross DA. PDK1, one of the missing links in insulin signal transduction? FEBS Lett 410: 3-10, 1997.
8. Cortright RN, Azevedo JL Jr, Zhou Q, Sinha M, Pories WJ, Itani SI, and Dohm GL. Protein kinase C modulates insulin action in human skeletal muscle. Am J Physiol Endocrinol Metab 278: E553-E562, 2000.
9. Evans JL, Goldfine ID, Maddux BA, and Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52: 1-8, 2003.
10. Friedman JE, Dohm GL, Leggett-Frazier N, Elton CW, Tapscott EB, Pories WP, and Caro JF. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest 89: 701-705, 1992.
11. Gaudreault N, Santure M, Pitre M, Nadeau A, Marette A, and Bachelard H. Effects of insulin on regional blood flow and glucose uptake in Wistar and Sprague-Dawley rats. Metabolism 50: 65-73, 2001.
12. Gosmanov AR, Schneider EG, and Thomason DB. NKCC activity restores muscle water during hyperosmotic challenge independent of insulin, ERK, and p38 MAPK. Am J Physiol Regul Integr Comp Physiol 284: R655-R665, 2003.
13. Gosmanov AR and Thomason DB. Insulin and isoproterenol differentially regulate mitogen-activated protein kinase-dependent Na(+)-K(+)-2Cl(-) cotransporter activity in skeletal muscle. Diabetes 51: 615-623, 2002.
14. Hajduch E, Alessi DR, Hemmings BA, and Hundal HS. Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47: 1006-1013, 1998.
15. Hajduch E, Litherland GJ, and Hundal HS. Protein kinase B (PKB/ Akt)-a key regulator of glucose transport? FEBS Lett 492: 199-203, 2001.
16. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, and Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 4: P4, 2003.
17. Hresko RC, Murata H, and Mueckler M. Phosphoinositide-dependent kinase-2 is a distinct protein kinase enriched in a novel cytoskeletal fraction associated with adipocyte plasma membranes. J Biol Chem 278: 21615-21622, 2003.
18. Hunt DG and Ivy JL. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol 93: 1638-1643, 2002.
19. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, and King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89: 11059-11063, 1992.
20. Itani SI, Ruderman NB, Schmieder F, and Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and 1kappaB-alpha. Diabetes 51: 2005-2011, 2002.
21. Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, and Czech MP. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci USA 100: 7569-7574, 2003.
22. Kido Y, Nakae J, and Accili D. Clinical review 125: the insulin receptor and its cellular targets. J Clin Endocrinol Metab 86: 972-979, 2001.
23. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, and Shulman GI. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108: 437-446, 2001.
24. Kim YB, Ciaraldi TP, Kong A, Kim D, Chu N, Mohideen P, Mudaliar S, Henry RR, and Kahn BB. Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects. Diabetes 51: 443-448, 2002.
25. Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, and Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104: 733-741, 1999.
26. Kim YB, Zhu JS, Zierath JR, Shen HQ, Baron AD, and Kahn BB. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes 48: 310-320, 1999.
27. Krook A, Bjornholm M, Galuska D, Jiang XJ, Fahlman R, Myers MG Jr, Wallberg-Henriksson H, and Zierath JR. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49: 284-292, 2000.
28. Krook A, Kawano Y, Song XM, Efendic S, Roth RA, Wallberg-Henrickson H, and Zierath JR. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 46: 2110-2114, 1997.
29. Kurowski TG, Lin Y, Luo Z, Tsichlis PN, Buse MG, Heydrick SJ, and Ruderman NB. Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes 48: 658-663, 1999.
30. Lawlor MA and Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910, 2001.
31. Lee AD, Hansen PA, Schluter J, Gulve EA, Gao J, and Holloszy JO. Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle. Am J Physiol Cell Physiol 273: C1082-C1087, 1997.
32. Maldonado MR, Chong ER, Oehl MA, and Balasubramanyam A. Economic impact of diabetic ketoacidosis in a multiethnic indigent population: analysis of costs based on the precipitating cause. Diabetes Care 26: 1265-1269, 2003.
33. Meyer MM, Levin K, Grimmsmann T, Perwitz N, Eirich A, Beck-Nielsen H, and Klein HH. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes. Diabetes 51: 2691-2697, 2002.
34. Oku A, Nawano M, Ueta K, Fujita T, Umebayashi I, Arakawa K, Kano-Ishihara T, Saito A, Anal M, Funaki M, Kikuchi M, Oka Y, and Asano T. Inhibitory effect of hyperglycemia on insulin-induced Akt/ protein kinase B activation in skeletal muscle. Am J Physiol Endocrinol Metab 280: E816-E824, 2001.
35. Patti ME, Virkamaki A, Landaker EJ, Kahn CR, and Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48: 1562-1571, 1999.
36. Rojas FA, Hirata AE, and Saad MJ. Regulation of IRS-2 tyrosine phosphorylation in fasting and diabetes. Mol Cell Endocrinol 183: 63-69, 2001.
37. Rossetti L, Smith D, Shulman GI, Papachristou D, and DeFronzo RA. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79: 1510-1515, 1987.
38. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, and Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15: 2099-2111, 2001.
39. Song XM, Kawano Y, Krook A, Ryder JW, Efendic S, Roth RA, Wallberg-Henriksson H, and Zierath JR. Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes 48: 664-670, 1999.
40. Tomas E, Lin YS, Dagher Z, Saha A, Luo Z, Ido Y, and Ruderman NB. Hyperglycemia and insulin resistance: possible mechanisms. Ann NY Acad Sci 967: 43-51, 2002.
41. Troussard AA, Mawji NM, Ong C, Mui A, St-Arnaud R, and Dedhar S. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278: 22374-22378, 2003.
42. Turinsky J and Damrau-Abney A. Akt kinases and 2-deoxyglucose uptake in rat skeletal muscles in vivo: study with insulin and exercise. Am J Physiol Regul Integr Comp Physiol 276: R277-R282, 1999.
43. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, and Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes 44: 790-795, 1995.
44. Virkamaki A, Ueki K, and Kahn CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103: 931-943, 1999.
45. Walker KS, Deak M, Paterson A, Hudson K, Cohen P, and Alessi DR. Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem J 331: 299-308, 1998.
46. Wang Q, Somwar R, Bilan PJ, Liu Z, Jin J, Woodgett JR, and Klip A. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 19: 4008-4018, 1999.
47. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283: E413-E422, 2002.
48. Yki-Jarvinen H, Helve E, and Koivisto VA. Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes 36: 892-896, 1987.
49. Zierath JR, Galuska D, Nolte LA, Thorne A, Kristensen JS, and Wallberg-Henriksson H. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 37: 270-277, 1994.
50. Zierath JR, Krook A, and Wallberg-Henriksson H. Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43: 821-835, 2000.